Viridian Therapeutics
VRDN
#5299
Rank
C$1.52 B
Marketcap
$18.70
Share price
-0.44%
Change (1 day)
7.82%
Change (1 year)

EPS for Viridian Therapeutics (VRDN)

EPS in 2023 (TTM): -$6.57

According to Viridian Therapeutics's latest financial reports the company's current EPS (TTM) is -$6.75. In 2022 the company made an earnings per share (EPS) of -$5.58 an increase over its 2021 EPS that were of -$10.50.

EPS history for Viridian Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.5717.67%
2022-$5.58-46.83%
2021-$10.50-73.94%
2020-$40.3044.73%
2019-$27.8422.94%
2018-$22.65-27.33%
2017-$31.17-91.47%
2016-$365.30-19.17%
2015-$451.95-75.48%
2014-$1,843582.47%
2013-$270.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.02-55.24%๐Ÿ‡บ๐Ÿ‡ธ USA